{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:27Z","timestamp":1792245747502,"version":"4.4.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Mucormycosis is a rare but a devastating and lifethreatening fungal infection caused by fungi of the order Mucorales usually in immunocompromised patients. Depending on the organs and tissues involved, there are sinus, pulmonary, gastrointestinal, orbital, cerebral, cutaneous and disseminated mucormycosis. Only sporadic cases of hepatic mucormycosis have been described. Hence, we present a complicated treatment management in a 16-month-old child with leukemia and generalized mucormycosis localized in the liver and in the gastrointestinal tract. The collaboration of a multidisciplinary team and appropriate therapy gave a chance not only to save the patient's life, but to carry out anticancer treatment, which resulted in leukemia remission. A 6-month course of isavuconazole and amphotericin B liposomal as well as surgical treatment led to the cure of the fungal infection.<\/jats:p>","DOI":"10.3389\/fmed.2022.844880","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T06:27:39Z","timestamp":1645770459000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["How to Treat a Child With a Concurrent Diagnosis of Leukemia and Generalized Mucormycosis? Case Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Patrycja","family":"Sosnowska-Sienkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"B\u0142aszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honorata","family":"Kubisiak-Rzepczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Ma\u0144kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Januszkiewicz-Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","article-title":"Mucormycosis","author":"Hern\u00e1ndez","year":"2021"},{"key":"B2","first-page":"461","article-title":"Mycoses and Algal infections. Weedon's Skin Pathology Essentials","author":"Johnstone","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3892\/etm.2014.1753","article-title":"Successful treatment of invasive gastric mucormycosis in a patient with alcoholic liver cirrhosis: A case report","volume":"8","author":"Lee","year":"2014","journal-title":"Exp Ther Med."},{"key":"B4","first-page":"534","article-title":"\u201cMucormycosis\u201d. Textbook of Medical Mycology","author":"Chander","year":"2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0039-3401992","article-title":"Mucormycosis","volume":"41","author":"Reid","year":"2020","journal-title":"Semin Respir Crit Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jiac.2018.06.013","article-title":"Invasive hepatic mucormycosis: A case report and review of the literature","volume":"25","author":"Karigane","year":"2019","journal-title":"J Infect Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4173246","DOI":"10.1155\/2017\/4173246","article-title":"A young, immunocompetent woman with small bowel and hepatic mucormycosis successfully treated with aggressive surgical debridements and antifungal therapy","volume":"2017","author":"Vikum","year":"2017","journal-title":"Case Rep Infect Dis."},{"key":"B8","unstructured":""},{"key":"B9","unstructured":"Mucormycosis. Fungal DiseasesCDC"},{"key":"B10","first-page":"51","article-title":"Subcutaneous and deep mycoses: Zygomucosis\/Mucormycosis. Cutaneous Manifestations of Infection in the Immunocompromised Host","author":"Grossman","year":"2012"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Drogari-Apiranthitou M","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"B14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01932420","article-title":"Mycosis mucorina: Paltauf A","volume":"102","author":"Paltauf","year":"1885","journal-title":"Arch Pathol Anat."},{"key":"B15","first-page":"1839","article-title":"Rhizopus, Rhizomucor, Absidia and other agents of systemic and subcutaneous zygomycoses","author":"Richardson","year":"2007"},{"key":"B16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01103455","article-title":"Cutaneous zygomycosis caused by Absidia corymbifera in a leukemic patient","volume":"130","author":"Lopes","year":"1995","journal-title":"Mycopathologia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"1","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B18","unstructured":"Pulmonary mucormycosis\n            PflegerR\n            WeerakkodyY\n          10.53347\/rID-28658"},{"key":"B19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1399-3062.2005.00092.x","article-title":"Localized cecal zygomycosis following renal transplantation","volume":"7","author":"Echo","year":"2005","journal-title":"Transpl Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11046-007-9022-y","article-title":"Gastrointestinal zygomycosis: a report of three cases","volume":"164","author":"Geramizadeh","year":"2007","journal-title":"Mycopathologia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica."},{"key":"B22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e02232","DOI":"10.1128\/AAC.02232-18","volume":"63","author":"Heidari","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/cid\/ciz159","article-title":"Kontoyiannis DP. Lack of toxicity with long-term isavuconazole use in patients with hematologic malignancy","volume":"69","author":"DiPippo","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1439-0507.2006.01299.x","article-title":"Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia","volume":"1","author":"Rickerts","year":"2006","journal-title":"Mycoses."},{"key":"B27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1086\/517067","article-title":"Successful treatment of disseminated mucormycosis with liposomal amphotericin B and surgery in a child with leukemia","volume":"26","author":"Maury","year":"1998","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.844880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T06:27:44Z","timestamp":1645770464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.844880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":27,"alternative-id":["10.3389\/fmed.2022.844880"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.844880","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"844880"}}